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ABSTRACT The purpose of the present study was to examine the characteristics of Na+ channel modification by batrachotoxin
(BTX) in cardiac cells, including changes in channel gating and kinetics as well as susceptibility to block by local anesthetic
agents. We used the whole cell configuration of the patch clamp technique to measure Na+ current in guinea pig myocytes.
Extracellular Na+ concentration and temperature were lowered (5-10 mM, 170C) in order to maintain good voltage control. Our
results demonstrated that 1) BTX modifies cardiac /Na. causing a substantial steady-state (noninactivating) component of /Na;
2) modification of cardiac Na+ channels by BTX shifts activation to more negative potentials and reduces both maximal 9Na
and selectivity for Na+; 3) binding of BTX to its receptor in the cardiac Na+ channel reduces the affinity of local anesthetics for
their binding site; and 4) BTX-modified channels show use-dependent block by local anesthetics. The reduced blocking potency
of local anesthetics for BTX-modified Na+ channels probably results from an allosteric interaction between BTX and local
anesthetics for their respective binding sites in the Na+ channel. Our observations that use-dependent block by local anesthetics
persists in BTX-modified Na+ channels suggest that this form of extra block can occur in the virtual absence of the inactivated
state. Thus, the development of use-dependent block appears to rely primarily on local anesthetic binding to activated Na+
channels under these conditions.
INTRODUCTION
Batrachotoxin (BTX) is a potent modifier of Na+ channels
in a variety of excitable cells and is thought to bind to the
channel at a binding site specific for lipid-soluble alkaloids
(toxin site II, see Ref. 1). Extensive electrophysiological
studies in nerve have shown that BTX inhibits inactivation,
shifts the voltage dependence of activation, and reduces ionic
selectivity ofNa+ channels (Ref. 2 and see Ref. 3 for review).
The effects of BTX on single nerve Na+ channels have pro-
vided a basis for the observations made in intact preparations,
demonstrating a reduced single channel conductance, in-
creased open time throughout a depolarizing test step, and a
pronounced increase in openings at negative potentials (4).
Additional reports have indicated that binding of BTX to
nerve Na+ channels decreases the binding affinity for local
anesthetics (LA) such as lidocaine, benzocaine, and procaine
(3). The mechanism for this drug interaction is unclear but
could be the result of interference of the BTX with local
anesthetic binding via an allosteric or a competitive inter-
action. Also, changes in state-dependent binding may result
from alterations in activation and inactivation caused by
BTX modification of Na+ channels (5).
In contrast to the large volume of information obtained in
nerve preparations, few electrophysiological studies have ex-
amined the effects of BTX on INa in heart. A number of
reports have described the effects of BTX to prolong the
action potential, increase cardiac force, and decrease resting
membrane potential in a variety of cardiac preparations (6,
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7). It is assumed that these actions are the result of an in-
creased cardiac Na+ channel open time causing increased
Na+ influx; consequently, the positive inotropic action of
BTX is thought to occur as the result of an increase in
Na+ leading to increased Ca2+ via sodium-calcium ex-
change (8).
Few voltage clamp studies of BTX effects on cardiac INa
have been performed to substantiate these suppositions.
Huang et al. (9) reported that there was less of a negative
voltage shift and no change in slope factor of the
conductance-voltage curve in neonatal rat myocytes com-
pared to nerve and that slow inactivation of INa was only
partially abolished. There is little information available about
the interactions between LA and BTX in heart. These con-
trasting results between nerve and cardiac Na+ channel re-
sponse to BTX modification may reflect the differences in
protein structure that underlie the two channel types.
The purpose of the present study was to characterize the
effects of BTX on cardiac Na+ channels, including alter-
ations in channel gating and current kinetics. In addition, we
wanted to characterize the interactions of BTX and LA in
cardiac Na+ channels. More specifically, we wanted to de-
termine if there is a decrease in affinity of modified channels
for LA in heart and if the change in LA binding affinity for
BTX-modified channels occurs as the result of drug binding
interactions or of decreased LA binding in the absence of an
inactivated state. A preliminary report of some of these ob-
servations has appeared in abstract form (10).
MATERIALS AND METHODS
Cell isolation procedures
Guinea pig ventricular myocytes were isolated by a modification of the
method described by Mitra and Morad (11). Briefly, a guinea pig was anes-
thetized with sodium pentobarbital (-30 mg, intraperitoneally), its chest
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was opened, and the heart was removed and suspended from a Langendorff
apparatus via an aortic cannula. The modified Tyrode's solution had the
following composition (in millimolar): NaCl, 135; KCI, 5.4; MgCl2, 1;
CaCl2, 1.8; glucose, 5.5; 4-(2-hydroxyethyl)-l-piperazineethanesulfonic
acid (HEPES), 10; NaH2PO4, 0.33; brought to pH 7.4 with NaOH. Retro-
grade perfusion of normal solution at 37°C was maintained at a constant
hydrostatic pressure of 100 cm of water. After a period of wash (5 min), the
perfusate was changed to an identical solution that was nominally Ca2+ free.
Perfusion with Ca2+-free medium continued for 3 min, at which time per-
fusion with enzyme solution was initiated. This solution contained colla-
genase (type XXIV, 0.24 mg/ml; Sigma Chemical Co., St. Louis, MO) and
protease (Sigma type A, 0.5 mg/mi). Perfusion was continued for 2.5-5 min.
At this time, the perfusate was switched to a KB medium for 5 min. The
composition of KB solution was as follows (in millimolar): KCI, 25;
KH2PO4, 10; KOH, 116; glutamic acid, 80; taurine, 10; oxalic acid, 14;
HEPES, 10; glucose, 11; brought to pH 7.0 with KOH. The heart was then
removed from the apparatus and placed in KB medium where it was minced
and filtered through nylon mesh (200 ,um). Cells were stored for up to 8 h
in KB medium at room temperature.
Electrophysiological recordings
Recordings of INa were made using a voltage clamp amplifier and whole cell
patch clamp techniques. Micropipettes were pulled from borosilicate cap-
illary tubing with filament (World Precision Instruments TW15OF, New
Haven, CT) on a P87 Brown-Flaming puller (Sutter Instruments, San Rafael,
CA) and had a resistance of about 0.8 Mfl when filled with internal solution.
In 30 cells, the time constant of the capacitative transient was 186 ± 10 ,us,
and the membrane capacitance was measured to be 209 ± 8 pF, yielding an
average series resistance of 0.89 MQl. The low access resistance allowed
measurements of peak currents of up to about 6 nA with a voltage error of
<5 mV in the absence of series resistance compensation. Consequently,
series resistance compensation was usually not required because of the low
access resistance obtained after sealing, as long as current amplitude was
<6 nA. In some experiments, slightly larger currents were accepted (e.g.,
Fig. 1) if current traces showed no other signs of poor voltage control such
as an "abominable notch," a delay in activation time or abrupt activation in
the threshold voltage range. Series resistance compensation was usually not
used, because it did not significantly improve the response time of our
recordings using these procedures, assuming that the other criteria for ad-
equate voltage control were met.
Pipettes were filled with solution of the following composition (in mil-
limolar): CsF, 145; NaF, 5; HEPES, 5; brought to pH 7.2 with CsOH. Re-
cordings of INa were made at 17°C by cooling the external solution as it
flowed through a peltier device into the experimental chamber at a rate of
1-2 ml/min. External solution had the following composition (in milli-
molar): NaCl, 5-10; MgCl2, 1.2; CsCl, 5; CaCl2, 1.8; tetramethylam-
monium-Cl, 125; glucose, 11; HEPES, 20; brought to pH = 7.4 with
tetramethylammonium-OH. The choice of solutions included internal F
which blocks Ca21 current and internal and external Cs' which blocks
nearly all inward rectifier K+ current thus leaving only tetrodotoxin-
sensitive INa (12).
Experimental procedures
The general experimental protocol was as follows. An aliquot of cell sus-
pension was placed in the experimental chamber, and the cells were allowed
to settle for about 10 min before superfusion with external solution was
begun. The pipette was placed in contact with the cell surface, and gentle
suction was applied. A high resistance seal (0.8-1 gigaohm) formed within
2 min. Additional suction was applied to break the membrane under the
pipette pore, allowing low resistance access to the intracellular space. Hold-
ing potential (Vh) was -140 mV in all experiments unless stated otherwise.
A series of voltage clamp protocols was then performed in the absence of
drug. BTX was then added to the superfusate at a predetermined concen-
tration (100 or 200 nM) and allowed to act for about 20 min.A modest effect
of BTX was detected after this period. At this time, a rapid train of pulses
to -20 mV (50 ms, 10 Hz) was initiated for 20-30 s. This pulse train was
repeated each min for 3-5 min until a stable effect of BTX was achieved
(3) as indicated by decreased peak current and the development of a large
steady-state current component. Superfusion with BTX was terminated after
25-35 min, and the effect of BTX was stable for the remainder of the
experiment (up to 2 h).
After recording voltage clamp protocols designed to measure effects of
BTX modification OfINa, either lidocaine HCl (Pfaltz and Bauer, Inc., Water-
bury, CT) or procaine HCI (Sigma) was then added to the superfusate in
concentrations ranging from 0.01 to 30 mM. These agents were diluted from
a concentrated stock (100 mM) in normal external solution. In some ex-
periments, phenytoin (Sigma) was tested at concentrations ranging from
0.003 to 1 mM. Phenytoin was diluted into external solution from a con-
centrated stock prepared in dilute NaOH. Recordings were made after 7-10
min of exposure to each concentration of the LA agent. In most experiments,
the cell was superfused with drug-free solution after LA in order to confirm
the reversibility of drug action as well as the continued effect of BTX. In
each case where recovery was attempted, BTX effects were almost fully
recovered despite the absence of BTX from the external solution for long
periods.
Data acquisition and statistics
Data were filtered at 5 KHz, digitized at 10 KHz, and stored on a PDP 11/73
computer (Digital Equipment Corporation, Maynard, MA). In most exper-
iments, capacity transients and linear leak were subtracted digitally off-line
by proportional scaling of traces recorded during +10 to +50 mV steps in
which no ionic current was evoked. Additional data analysis was performed
off-line following completion of the experiment using locally developed
algorithms. Fitting routines used a least-squares algorithm for single ex-
ponential or Boltzmann fit. Data presented here are representative of at least
three experiments of each type.
Comparisons of two sample means were made using Student's t test.
Paired t tests were used to compare two sample means when a cell served
as its own control. A one-way analysis of variance of paired samples was
used when two or more groups were compared, such as in experiments
where multiple concentrations of one agent were tested. Differences be-
tween group means were evaluated with the Newman-Keuls test. A test was
considered to be significant when p < 0.05. Data are presented as mean +
SE.
RESULTS
Effects of BTX on /Na in guinea pig myocytes
The characteristic effects of exposure to BTX (100 nM) are
shown in Fig. 1. In control (Fig. 1 A), voltage clamp steps
from a holding potential of -140 mV to test potentials pos-
itive to threshold show normal rapid activation until peak
inward current was achieved, followed by a rapid phase of
inactivation. In the presence of BTX (Fig. 1 B), normal ac-
tivation was followed by a failure of complete inactivation,
leaving a large component of steady-state (ss) current re-
maining at the end of the 100-ms test pulse.
The inset of Fig. 1 B shows the approach we used to dis-
tinguish between BTX-modified and unmodified channels.
Since unmodified channels inactivate completely within
about 100 ms, whereas modified channels do not inactivate
for many seconds, we used this difference in kinetics to dis-
tinguish between the rapidly inactivating (peak - ss) current
which represents unmodified channels and the ss current
which represents modified channels. A similar approach was
used by Khodorov (3) to distinguish between the two pop-
ulations of Na+ channels in nerve.
Fig. 1 C shows the current-voltage relationships for the ss
and peak - ss (p - ss) current components. Both control and
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FIGURE 1 Effects of 100 nM BTX on cardiac INa* (A) Current recordings
obtained from a series of voltage steps to the potentials indicated under
control conditions (leak and capacity subtracted). The effects of BTX are
illustrated in B. Following the peak current, each current trace demonstrates
a steady-state (ss), noninactivating component. This occurs with both in-
ward and outward currents. Between -60 and -70 mV, there is an inward
current component that shows a rapid phase of inactivation prior to relax-
ation to the ss component. The inset of B shows the method for separating
the inactivating from the noninactivating component; BTX-modified current
is represented by the ss component, whereas the unmodified current is ob-
tained by subtracting ss from the peak current (p - ss). C shows the current-
voltage relationships for this experiment under control conditions (peak
current, 0) and after exposure to BTX where the two current components
have been separated into unmodified channels (p - ss, 0) and modified
channels (ss, A).
p - ss current activated between -70 and -60 mV and
reached a maximum at about -40 mV. Reversal potential was
nearly 0 mV, reflecting the fact that [Na+] in both external
and internal solutions was the same (5 mM). In contrast, ss
currents show the usual characteristics ofBTX modification,
including a negative shift of reversal potential (-10 mV) and
of activation as well as a failure to inactivate during the
100-ms test pulse. These characteristics ofBTX modification
were also clearly evident in seven additional cells studied
after exposure to 200 nM BTX, where the shift in reversal
potential was -11.9 + 3.25 mV (p < 0.001) and the shift in
activation threshold potential was -50 + 2.2 mV (p <
0.001).
The effects of BTX on Na+ conductance (gNa) as calcu-
lated from the peak current-voltage relationships are illus-
trated in Fig. 2. The non-normalized gNa-V curves are shown
in Fig. 2 A; BTX modification caused a shift in the threshold
for activation of nearly -40 mV and, presumably, the loss of
unmodified channels to the modified pool accounts for the
decrease in maximal unmodified gNa- When these results are
normalized to compare modified and unmodified channels to
control (Fig. 2 B), the negative shift of the modified channels
is quite apparent as is the decrease in the slope factor, s. The
midpoint, Vm, of the normalized gNa-V relationship shifted
from -51.6 mV in control to -57.1 mV inp - ss (unmodified)
and -77.2 mV in ss (modified) current. The slope factors for
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FIGURE 2 Effects of BTX on the voltage dependence of peak Na+ con-
ductance (gNa). (A) Absolute values of peak gNa before exposure to BTX
(-) and both peak - ss INa (0) and ss INa (U) after 30 min of exposure to
BTX. (B) Normalized gNa for the same data as in A. The gNa values were
calculated according to the equation gNa = INa/( -4V-,) where INa is the
absolute value ofNa+ current, Vt is the test potential, and Vre is the reversal
potential. The values of V14. were calculated from the best least-squares
linear fit to the data ± 20 mV to the approximate voltage where current was
0. The values ofgNa and V1 - Vrev were then fitted to a Boltzmann distribution
from which midpoint (Vm) and slope (s) were calculated according to the
equation g = gmax/{ 1 + exp [(Vm - V)/s] }, where V is the test potential and
gmax is the maximal Na+ conductance.
these relationships were 4.4, 5.7, and 10.8 mV, respectively.
The summarized results of seven cells (top of Table 1) show
that control and unmodified INa had nearly the same slope but
that there was a small shift in Vm. The negative shift in Vm
of unmodified INa compared to control can probably be at-
tributed to the time-dependent negative shift of activation
(and possibly that of inactivation as well) that occurs as a
result of the unavoidable internal dialysis with pipette so-
lution (13, 14). For example, our measurement of a -14 mV
shift in unmodified INa during the 20-30-min period of ex-
posure to BTX is very much in line with the 0.47 mV/min
shift found by Hanck and Sheets (14). In a separate series of
control experiments, we also found that Vm shifted by about
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TABLE I Effects of BTX on Na+ conductance (gNa) in guinea
pig heart (n = 7)
Vm S
BTX100nM mV
Control -43.2 ± 1.67 5.7 ± 0.39
Unmodified INa -57.1 ± 3.40* 5.7 ± 0.70
Modified INa -81.2 ± 3.49* 9.4 ± 0.53t
BTX 200 nM
Control -41.6 ± 1.29 5.8 ± 0.17
BTX -84.4 ± 1.33* 9.3 ± 0.22*
Data were obtained from a single Boltzmann fit to the relationship between
gNa and test voltage as described in the legend of Fig. 2. Vm represents the
voltage midpoint and s is the slope factor of this relationship.
* P < 0.01 compared to control.
P < 0.001 compared to control and unmodified INa. Data are presented as
mean ± SE.
-7 mV within a 20-30-min period (unpublished observa-
tions). In contrast, BTX modification produced a large and
significant shift in the Vm and increase in the slope factor of
this relationship.
In a separate series of experiments in which cells were
exposed to 200 nM BTX, very little inactivating current re-
mained after BTX-modification (approximately 25 min).
The hyperpolarizing shift in Vm and the increase in slope
factor were nearly the same as that which occurred during
exposure to the lower concentration ofBTX (bottom ofTable
1). These results also confirm that the ss current recorded
following exposure to 100 nM BTX represents modified
channels.
The effects of 100 nM BTX on the voltage dependence of
steady-state INa availability (h.) are shown in Fig. 3. In con-
140 *100 -60
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FIGURE 3 Effects ofBTX on the voltage dependence of steady-state INa
availability (h.). The V-h. relationship was generated using a protocol in
which a 1-s voltage pulse was applied to various conditioning potentials
followed by a return to a test potential (Vi) of either -30 or -90 mV. Each
pulse pair was delivered after a 10-s interval. Closed circles indicate values
of h. before exposure to BTX, open circles represent peak - ss current, and
closed squares indicate ss current following 25 min of exposure to BTX
(Vt = -30 mV); open squares indicate peak inward current at Vt = -80 mV.
The fitted curves were obtained using the following form of the Boltzmann
equation: h. = l/{1 + exp[(V - VA)lk]), where V1/ is the voltage at half
inactivation, k is the slope factor, and V is the test voltage.
trol, the voltage midpoint of the h. curve (V½/,) was -81.9 mV,
and the slope factor (k) was 4.7 mV. Following exposure to
BTX for 26 min, the unmodified current showed little change
in k (3.7 mV), and Vl/2 was shifted by -16 mV. This shift in
V½/, is similar to time-matched control values of about -9 mV
(unpublished observations) and the value expected from the
work by Hanck and Sheets (14) based on a shift of -0.41
mV/min. In contrast, modified current showed little inacti-
vation (67% of maximal current remaining) even at condi-
tioning potentials as low as -20 mV. For purposes of com-
parison, a second protocol was run which differed from the
first only in test potential, Vt = -80 mV, which was chosen
because only modified channels open at this potential. A sim-
ilar fraction of modified current remained under these con-
ditions (80%), demonstrating the close similarity between h.
of BTX-modified Na+ channels alone (V, = -80 mV) and
of ss current obtained at a Vt = -30 mV. Similar results were
obtained in six additional cells and indicate that the rapidly
inactivating current component shows normal inactivation
gating, whereas the noninactivating, ss component demon-
strates the changes in Na+ channel availability characteristic
of BTX-modified channels.
Effects of BTX on recovery from inactivation
We also observed that the rate of recovery from inactivation
was slowed by BTX modification of cardiac Na+ channels.
Fig. 4 shows results obtained using a protocol in which in-
activation was allowed to develop at -20 mV for 1 s, after
which membrane potential was returned to -140 mV for a
variable interval (1-3000 ms) after which a test pulse to -100
mV was imposed to assess how much modified current had
recovered (see inset, Fig. 4 A). Under control conditions,
recovery was extremely rapid and was completed within 250
ms. The inset ofA shows original current recordings of both
conditioning and test pulses ranging from 1-3000 ms. The
earliest test pulse at 1 ms showed no signs of activation,
possibly because the return to Vh was too brief to allow de-
activation of modified channels. Subsequent current re-
sponses occurring after longer recovery intervals showed
clear evidence of reactivation but were similar in steady-state
amplitude until after 7 ms (A, inset), at which time current
amplitude began to increase (A). Further analysis of the un-
recovered fraction of modified INa revealed that the rate of
recovery was biexponential (Fig. 4 B) with fast and slow time
constants of 75 and 1064 ms, respectively, compared to 4.3
and 78 ms in control. The inset of B shows a graph with an
expanded time scale which more clearly illustrates the delay
in recovery that occurs during brief intervals (<10 ms).
Nearly identical results were obtained in all three experi-
ments of this type, with control fast and slow time constants
of4.8 ± 0.66 and 80.1 ± 4.57 ms in control compared to 58.1
± 11.8 and 862 ± 158 ms following BTX modification. The
delay in recovery was consistent in each experiment (ap-
proximately 7 ms). These results demonstrate that modified
channels show a delay in recovery from inactivation fol-
lowed by a biexponential recovery rate that suggests that at
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FIGURE 5 Effects of lidocaine (0.1-30 mM) on BTX-modified INa. This
figure shows the effects of several concentrations of lidocaine on current
evoked at a test potential of -30 mV in a BTX-treated myocyte (100 nM).
The trace indicated by 0 was obtained prior to addition of lidocaine to the
external solution. Each concentration of lidocaine was allowed to equilibrate
_a for 7-10 min before the concentration was increased. Inset: current record-
ings are presented as subtracted traces (peak current - steady state) in order
to indicate block of unmodified current only.
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FIGURE 4 Rate of recovery of BTX-modified INa from inactivation. (A)
Rate of recovery from inactivation developed during a 1-s conditioning
pulse to -20 mV as assessed after a variable recovery period at -140 mV
and during a test pulse to -100 mV (Vh = -140 mV). The inset shows a
schematic representation of the protocol and original current recordings
obtained during exposure to BTX (200 nM, 25 min) which are plotted on
the graph as open circles. Closed circles indicate values obtained in control.
(B) Semi-logarithmic transform of the unrecovered fraction of INa. The inset
is a graph with an expanded time scale of the first 50 ms of B, showing the
delay in the onset of recovery.
least two, and possibly three, inactivated states are prevalent
in BTX-modified channels.
Effects of lidocaine on unmodified and
BTX-modified /Na
Fig. 5 shows the single pulse ("tonic") blocking effects of
different concentrations of lidocaine on both components of
INa. The figure shows the effects of lidocaine on INa after
treatment with 100 nM BTX at a test potential of -30 mV.
The inset shows the same current traces presented as
subtracted traces (p - ss). The lowest concentration of
lidocaine (0.1 mM) reduced peak current by 20% but had no
effect on ss. When lidocaine concentration was increased to
1 mM, the p - ss current was blocked by an additional 25%,
while ss current showed the first evidence of block, a re-
duction of maximal ss current by about 10%. When lidocaine
concentration was increased to 3 mM, nearly all of this cur-
rent was blocked (inset). However, less than 30% of the mod-
ified current was blocked. Greater block occurred when the
concentration of lidocaine was further increased to 10 mM,
and nearly all modified current was blocked when the
lidocaine concentration was increased to 30 mM. These re-
sults demonstrate that unmodified Na+ channels are more
sensitive to block by lidocaine than are BTX-modified chan-
nels. This decrease in sensitivity to block by LA was also
observed with procaine and phenytoin (see below).
Concentration dependence of procaine and
lidocaine block of unmodified and modified INa
Fig. 6 summarizes the concentration dependence of single
pulse INa block by lidocaine (A) and procaine (B). Block was
assessed at a test potential of -20 mV from a holding po-
tential of -140 mV. The filled circles show the effects of the
local anesthetic agent alone in the absence ofBTX. The num-
ber of experiments for each data point ranged from 5 to 13.
The effects of increasing drug concentration on unmodified
and BTX-modified channels are shown in the figure. The
unmodified current had virtually the identical sensitivity to
anesthetic block as control current, whereas BTX modifi-
cation reduced the sensitivity to block by both local anes-
thetics. In A, the control apparent dissociation constant, Kd,
for lidocaine was 0.54 mM which was very similar to the
value obtained for unmodified current (0.69 mM). In con-
trast, Kd for modified current was 11.12 mM, indicating a
decrease in affinity for lidocaine binding by about 15-fold.
In B, the Kd for procaine in untreated myocytes was 0.81 mM
compared to 0.82 mM in unmodified current of BTX-treated
B
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FIGURE 6 Concentration dependence for procaine and lidocaine block of
unmodified and modified 'Na. (A) Summarizes effects of lidocaine on 'Nd
in control (a) and after exposure to BTX (100 nM), giving both unmodified
(0) and modified (A) current components. Curves were fitted to a single
binding site model using the equation: y =1/[1 + (Kd/x)] where x is drug
concentration, y is normalized current amplitude, Kd is the apparent drug
dissociation constant, and the Hill coefficient is assumed to equal 1. B
applies the same analysis to block by procaine. Values were taken from
current recordings obtained during a test voltage step to -20 mV following
leak and capacity subtraction. Each point represents the mean + SE of five
to 13 experiments.
cells. The Kd for modified channels was 14.66 mM, indi-
cating a 17-fold decrease in binding affinity for modified
channels compared to unmodified channels.
Although not indicated in these figures, we also tested the
effects of BTX modification on binding of phenytoin to car-
diac Na+ channels. We found that the Kd for unmodified
channels was 0.33 mM, whereas that in modified channels
was 1.9 mM (n = 3), representing an increase of nearly
5-fold. This represents only a modest decrease in binding
affinity compared to the other agents tested under identical
experimental conditions.
These results demonstrate that BTX modification of car-
diac Na+ channels decreases the blocking potency for all
three local anesthetic agents tested. Despite the similarity in
the amount of decrease in potency for procaine and lidocaine,
however, BTX appears to cause less of an increase in Kd for
phenytoin than for the other two agents.
Use-dependent block of BTX-modified /Na by local
anesthetics
We studied the effects ofBTX modification ofNa+ channels
on use-dependent block in cardiac cells. Since use-dependent
block is usually the result of drug interactions with activated
and/or inactivated channels, we expected that use-dependent
block by local anesthetic agents would by altered by mod-
ification of channel inactivation (and possibly activation) by
BTX. We chose to examine the development of use-
dependent block in BTX-modified channels by taking ad-
vantage of the shift in activation voltage caused by BTX (200
nM). Consequently, the development of use-dependent block
exclusively in modified channels was assessed by applying
a train of 20 pulses from Vh = -140 mV to a test potential
of -90 mV, a voltage 10-20 mV negative to the activation
range for unmodified channels but within the range of ac-
tivation of modified channels.
The effects of lidocaine and procaine on BTX-modified
INa during a train of 20 pulses from -140 to -90 mV (100-ms
duration, 500-ms interpulse interval) are shown in Fig. 7.
Prior to addition of local anesthetic (A), the slow activation
rate and virtual absence of INa decay of the first pulse of the
train indicate that nearly all INa activated under these con-
ditions was the result of opening of BTX-modified Na+
A B C
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FIGURE 7 Use-dependent block of BTX-modified INa by local anesthet-
ics. Use-dependent block was tested by applying a train of 20 pulses, 100
ms in duration with an interpulse interval of 500 ms. Vh = -140 mV. Test
potential was -90 mV in order to activate only BTX-modified channels. The
current amplitude is plotted as a function of the pulse number during the
train. (A) Current responses following exposure to BTX (200 nM); (B)
responses to test pulses in the presence of lidocaine (3 mM for 10 min); (C)
responses to procaine (3 mM for 10 min). Recordings were not leak or
capacity subtracted; (D) normalized current magnitude for each test pulse
from the data in A-C.
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channels. The maximal amplitude of the second pulse was
slightly smaller than that of the first pulse but subsequent
pulses were nearly identical in magnitude thereafter. During
exposure to lidocaine (3 mM for 10 min (B)), the first pulse
was markedly decreased compared to control (tonic block).
There was a marked decrease in peak amplitude for each of
the next seven pulses, after which a steady state was
achieved.
Washout of lidocaine from and addition of procaine to the
external solution (3 mM for 10 min (C)) caused the reap-
pearance ofuse-dependent block during the subsequent pulse
train. The effects of procaine were also eliminated after a
15-min recovery period in drug-free superfusate (not shown).
The development of use-dependent block is compared for
each condition in D, which shows normalized current mag-
nitude throughout the pulse train. Lidocaine caused a de-
crease of 23% and procaine reduced current by 17% com-
pared to the first pulse, whereas ss current declined by only
5% following exposure to BTX alone. In a total of seven
cells, BTX-modified INa declined by 4.4 ± 1.0%, whereas
both lidocaine and procaine caused a significant use-
dependent decrease in INa magnitude (20.3 ± 1.9% and 17.7
± 5.6%, p < 0.01 for each). Although not studied system-
atically, we also observed that the amount and onset of use-
dependent block were influenced by test pulse rate (inter-
pulse intervals ranging from 300 to 1000 ms) and duration
(10-100 ms).
These results demonstrate that use-dependent interactions
between local anesthetic agents and BTX-modified cardiac
Na+ channels are maintained despite the fact that drug af-
finity for these channels has been diminished. More impor-
tantly, the persistence of use-dependent block under condi-
tions where little inactivation is allowed to develop suggests
that repetitive Na+ channel activation plays a very important
role in and is, perhaps, primarily responsible for the devel-
opment of use-dependent block under these experimental
conditions.
DISCUSSION
Characteristics of BTX modification of cardiac /Na
Our results demonstrate that modification of Na+ channels
by BTX reduces gNa as well as the selectivity of the channel
for Na+, as evidenced by a negative shift in reversal poten-
tial. In addition, normal channel gating is markedly altered
by BTX, as indicated by the negative shift in activation volt-
age and the gNa-V relationship as well as the abolition of the
normal inactivation process, just as they are in nerve (3).
These observations are similar to those made in neonatal rat
cardiac cells by Huang et al. (9); however, those authors
reported that preincubation with 1 ,uM BTX for 2 h was
required to produce partial loss of inactivation, whereas ex-
posure to 8 ,uM was necessary to cause nearly complete fail-
ure to inactivate. In the present experiments, the voltage mid-
point for activation was shifted to more negative potentials
by nearly -43 mV, a value that is approximately halfway
between those reported in neuroblastoma (-50 mV (15)) and
in rat neonatal heart (-30 mV, and see Ref. 9 for compari-
sons). Given the known differences in pharmacological sen-
sitivity and current gating between nerve and heart, it is
somewhat surprising that activation in adult guinea pig heart
responds so differently from neonatal rat heart. The contrast
is retained in the effects of BTX on the slope factor of the
gNa-V relationship; Huang et al. (9) reported that BTX had
no effect on the slope factor, whereas our results are similar
to those of Tanguy and Yeh (5) in squid axon and in other
nerve preparations (3) showing a marked decrease in slope
factor. We found that there was a significant increase in slope
factor during exposure to 200 nM BTX . However, the lack
of a period of rapid stimulation even in the presence of BTX
could explain the reduced shift in conductance and the ap-
parent decreased sensitivity reported in rat neonatal heart
compared to other preparations. The highly lipid-soluble,
very slowly acting BTX seems to require a period of rapid
repetitive activations in order to achieve full activity (5, 16).
This behavior is consistent with its reported action to interact
with the Na+ channel in the open state (3, 5, 16, 17). Al-
ternatively, it is possible that rat neonatal cardiac cells simply
have a lower sensitivity to BTX than adult guinea pig my-
ocytes. The basis for these differences in activation remains
to be determined.
Our results also indicate that fast inactivation (<100 ms)
is almost completely abolished in modified channels. In con-
trast, slow inactivation (i.e., that which develops over 1 s) is
only partly abolished by BTX, as also reported in rat heart
by Huang et al. (9). Although we did not examine the effects
ofBTX on very slow inactivation (>1 min), Huang et al. (9)
reported that BTX also reduced this component of inacti-
vation by 70-75% in neonatal rat heart.
Recovery from inactivation, once it has developed, was
biexponential just as it is in normal cardiac INa. Similar re-
sults were recently reported in GH3 cells (18) and taken to
mean that there are at least two inactivated states for BTX-
modified channels, just as there are in normal channels. How-
ever, unlike the results in GH3 cells, modified cardiac cells
showed a delay in recovery from inactivation suggesting the
presence of a third process governing recovery rate of BTX-
modified channels, one that acts as a rate-limiting or ab-
sorbing state from which modified channels must exit before
recovery from inactivation can begin. The many profound
differences between experimental conditions and methods
might also contribute to the disparate results obtained in the
two preparations, and additional study is required to describe
more completely the processes underlying the recovery from
inactivation of BTX-modified INa-
In agreement with other observations in nerve, we also
found that BTX-induced modification of cardiac INa was ex-
tremely stable over time once the full effect was achieved at
any given BTX concentration (3, 19). This last property made
it possible to stop superfusion with BTX after its full effect
was realized and continue with the experiment for up to 2 h
without reversal of BTX effects.
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Effect of BTX to alter blocking potency of local
anesthetics
One of the most important pharmacological characteristics of
Na+ channels is their sensitivity to block by LA. In heart, this
effect has important clinical applications since most of the
clinically effective antiarrhythmic agents belong to this class
of drugs. It is assumed that LA block of INa in excitable cells
is the result of a specific interaction with a binding site on
the channel protein. This binding site is presumably located
in the lipophilic core of the channel, since a lipophilic path-
way is thought to be important to drug access to and removal
from the channel (20, 21). In addition, binding of LA to their
receptor is thought to be dependent on the channel state,
controlled either by changes in binding affinity with channel
state (modulated receptor hypothesis (20, 21)) or by changes
in access to a receptor with a constant affinity (guarded re-
ceptor hypothesis (22)).
The first electrophysiological evidence indicating the abil-
ity of BTX to reduce the binding of LA to their receptor on
the Na+ channel was reported by Khodorov et al. (23). These
investigators found that BTX "protected" modified Na+
channels from block by procaine. Numerous studies have
since reported that BTX modification also reduces the block-
ing potency of other LA in electrophysiological experiments
(see Ref. 3) and using radioisotope flux measurements (24).
These reports complement biochemical studies showing that
different LA reduced binding affinity of a radiolabeled BTX
analog in isolated nerve preparations (25). Taken together,
these results strongly suggested that there is a competitive
interaction between binding ofBTX and LA as demonstrated
directly by Huang and Ehrenstein (26) using ion flux mea-
surements.
Previous electrophysiological results indicated that BTX
increased Kd for tonic (first-pulse) block and completely
abolished use-dependent block, regardless of the type of LA
tested; these included agents considered to have a high af-
finity for activated channels, such as QX-572, quinidine, and
ethmozine as well as those thought to bind preferentially to
inactivated channels, including lidocaine and trimecaine (16,
27, 28). The increase in values for Kd was from 0.48 mM in
normal channels to 5.62 mM in modified channels for
procaine and from 1.21 mM in unmodified channels to 5.66
mM in modified channels for lidocaine in neuroblastoma
cells (2).
Our results in cardiac cells demonstrate striking qualitative
similarities to those described in nerve. The affinity for block
of unmodified channels by LA was nearly identical to that of
previously untreated cardiac channels. In contrast, BTX
modification caused nearly the same decrease in affinity for
lidocaine (15-fold decrease) and for procaine (17-fold de-
crease). These decreases in binding affinity are greater than
corresponding changes reported in nerve (4-fold decrease for
lidocaine, 11-fold for procaine (Zubov et al., 1983)). The
basis for these differences is not yet clear but could be the
channel subtypes from the two tissues involved. Interest-
ingly, phenytoin caused less of a decrease in binding affinity
(about 5-fold) which is more consistent with the results in
nerve.
Our values for Kd were calculated using a single site model
fit to the concentration-effect curve. The Hill coefficient (nH)
was assumed to be 1 in these calculations and the results were
well fitted in general by this scheme. The only apparent ex-
ception to this was the block of unmodified INa by procaine,
where an n = 1.2 improved the fit somewhat (data not
shown); however, the fit is surprisingly good when consid-
ering the fact that these data, in fact, represent subtracted
values of p - ss current. We suspect that the error inherent
in this technique provides a more likely explanation for a
deviation from n = 1 than cooperativity of procaine binding
to unmodified channels following partial modification of INa
by BTX.
Although the present results do not provide a precise ex-
planation for the reduction of blocking potency of LA for
BTX-modified INa, it is possible that BTX binding to and
modification of cardiac Na+ channels prevents LA binding
via a drug interaction in the channel (24, 25, 29). This could
be the result either of a direct interaction at a common bind-
ing site suggesting a competitive antagonism (26) or, as ap-
pears more likely, an indirect interaction resulting from si-
multaneous occupation of separate binding sites that
produces allosteric interactions of the ligands (29). It is also
worth noting that, after complete LA block of BTX-modified
channels was achieved, nearly a full recovery to the BTX-
modified state was accomplished during superfusion with
drug-free solution without rapid repetitive stimulation, sug-
gesting that BTX was still bound to the channels. Thus, the
interaction between agents did not result in a displacement
of BTX from its receptor, a result also reported in nerve (3)
that could possibly lend support to an allosteric rather than
a competitive interaction between LA and BTX.
Use-dependent block by local anesthetics of
BTX-modified channels
Our results show that use-dependent block by procaine and
lidocaine persists in BTX-modified cardiac Na+ channels for
trains of pulses with durations up to 100 ms. Our results are
in distinct contrast to those reported for unmodified and
BTX-modified channels in nerve (3) in which rapid repetitive
pulses of durations up to 50 ms in nerve failed to induce any
appreciable use-dependent decline in current amplitude.
Even agents with strong affinity for activated channels such
as strychnine (28) failed to produce use-dependent block in
nerve, suggesting that the conventional state-dependent
binding affinities no longer determined the binding interac-
tion between LA and modified Na+ channels.
If use-dependent block by certain LA is the result of a
higher affinity for inactivated than for activated channels, as
might be expected from the modulated receptor hypothesis
result of differences in binding site characteristics of the Na (
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prevent this high affinity binding from producing use-
dependent block. Consequently, we expected that the loss of
inactivation (and/or alterations in activation) would in turn
alter the drug affinity for state-dependent binding to the re-
ceptor on the BTX-modified Na+ channels and thus result in
the reduction or absence of use-dependent block. Our ex-
perimental results demonstrated quite clearly, however, that
use-dependent block of BTX-modified INa developed quite
normally. This observation suggests that the presence of nor-
mal inactivation might be unnecessary for the development
of use-dependent block in the heart.
Our original supposition arose from reports of an impor-
tant role for the inactivation gate in use-dependent block of
INa by LA as suggested by several lines of evidence. First,
voltage-dependent Na+ channel availability is decreased (in-
activation is increased) in the presence of LA (20, 21). Sec-
ond, gating charge immobilization occurs both in inactivated
nerve Na+ channels and in use-dependent blocked Na+
channels (30). Third, removal of fast inactivation by pronase
or N-bromoacetamide abolishes or reduces the ability of the
quaternary derivative of lidocaine, QX-3 14, to produce use-
dependent block Of INa in nerve (31, 32). Finally, the time and
voltage dependence of lidocaine block indicates an important
contribution of drug interaction with inactivated channels to
the development of use-dependent block in several cardiac
preparations (12, 33, 34).
Results from several reports using other Na+ channel tox-
ins, however, suggest that the loss of rapid inactivation in
itself is inadequate to prevent use-dependent block by LA and
found similar results to ours. In nerve, LA continued to pro-
duce use-dependent block when inactivation was markedly
slowed by either anthopleurin-A toxin (from Anthopleura
xanthogrammica) or by veratridine (35). We have found that
blocking fast inactivation in cardiac cells under the same
experimental conditions as those employed here with
anthopleurin-A does not prevent use-dependent block by ei-
ther lidocaine or procaine (Wasserstrom et al., unpublished
observations). In addition, longer pulses caused more block,
suggesting that interaction with open channels is responsible
for use-dependent block under these conditions. Since mod-
ification of inactivation with these toxins failed to prevent
use-dependent block by LA, it therefore seems unlikely that
an intact inactivation process alone is responsible for use-
dependent block.
Other observations in nerve shed additional light on the
basis for use-dependent block in normal and modified Na+
channels. Yeh and Tanguy (36) and Wang et al. (37) dem-
onstrated that use-dependent block by QX-3 14 persists after
the elimination of fast inactivation with chloramine-T. The
basis for this maintained use-dependent block may be that
QX-3 14 is trapped in the open channel during repolarization
but that the drug itself then induces the modified channel to
enter an inactivated state (38). Their conclusion was that both
association with the activated state and the ability of a drug-
bound channel to enter an inactivated, drug-bound state are
required for the use-dependent block by LA. It is clear that
use-dependent block is a complex manifestation of several
processes occurring simultaneously in the Na+ channel and
that, in all likelihood, LA interactions with both activated and
inactivated channels will ultimately determine the charac-
teristics of use-dependent block.
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